Volume | 736 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 10.10 | Mínimo Máximo |
|||||
Minimo del Dia | 9.85 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Surrozen Inc | SRZN | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
10.10 | 9.85 | 10.10 | 10.00 | 10.0999 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
65 | 736 | US$ 10.06 | US$ 7,405 | - | 4.50 - 16.19 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
15:00:00 | 2 | US$ 9.61 | USD |
Información Financiera Surrozen Inc SRZN
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
20.38M | 2.04M | - | 0 | -43.04M | -21.12 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Surrozen Inc SRZN
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
03/4/2024 | 07:40 | GlobeNewswire Inc. | Surrozen Publishes Study in 'Respiratory Research'.. |
01/4/2024 | 07:30 | GlobeNewswire Inc. | Surrozen Announces Safety, Pharmacodynamic and Liver.. |
01/4/2024 | 07:30 | GlobeNewswire Inc. | Surrozen Announces up to $192.5 Million Private Placement of.. |
07/2/2024 | 05:16 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
07/2/2024 | 05:10 | Edgar (US Regulatory) | Form 8-K - Current report |
22/1/2024 | 16:24 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
18/1/2024 | 07:41 | Edgar (US Regulatory) | Form 8-K - Current report |
18/1/2024 | 07:30 | GlobeNewswire Inc. | Surrozen Provides Corporate Update on Clinical Programs |
18/12/2023 | 20:26 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
13/12/2023 | 16:21 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
13/12/2023 | 16:14 | Edgar (US Regulatory) | Form 8-K - Current report |
11/12/2023 | 15:11 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
Histórico de Datos SRZN
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 8.14 | 11.00 | 8.14 | 9.91 | 10,737 | 1.86 | 22.85% |
1 Month | 10.86 | 11.825 | 8.14 | 10.21 | 13,177 | -0.86 | -7.92% |
3 Months | 9.19 | 16.19 | 8.14 | 11.22 | 17,710 | 0.81 | 8.81% |
6 Months | 6.5235 | 16.19 | 4.50 | 7.81 | 40,356 | 3.48 | 53.29% |
1 Year | 9.795 | 16.19 | 4.50 | 8.56 | 72,271 | 0.205 | 2.09% |
3 Years | 143.25 | 210.00 | 4.50 | 31.18 | 180,498 | -133.25 | -93.02% |
5 Years | 143.25 | 210.00 | 4.50 | 31.18 | 180,498 | -133.25 | -93.02% |